Balchem Co. (NASDAQ:BCPC) Shares Bought by Barclays PLC

Barclays PLC lifted its stake in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 10.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 67,213 shares of the basic materials company's stock after purchasing an additional 6,436 shares during the period. Barclays PLC owned approximately 0.21% of Balchem worth $10,955,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in BCPC. Westside Investment Management Inc. bought a new position in Balchem in the third quarter valued at $27,000. Covestor Ltd lifted its stake in shares of Balchem by 93.8% in the fourth quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock worth $26,000 after acquiring an additional 76 shares during the period. R Squared Ltd bought a new position in shares of Balchem during the 4th quarter worth approximately $29,000. Wilmington Savings Fund Society FSB bought a new position in shares of Balchem in the 3rd quarter worth $35,000. Finally, Federated Hermes Inc. purchased a new position in shares of Balchem during the fourth quarter valued at approximately $33,000. 87.91% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

BCPC has been the topic of several recent research reports. Sidoti raised shares of Balchem to a "hold" rating in a report on Tuesday, February 25th. HC Wainwright restated a "buy" rating and issued a $190.00 price objective on shares of Balchem in a research report on Monday, February 24th. Finally, StockNews.com lowered shares of Balchem from a "buy" rating to a "hold" rating in a report on Tuesday, February 25th.

Balchem Trading Down 0.5 %

Shares of NASDAQ:BCPC traded down $0.79 during trading on Friday, hitting $153.41. The company had a trading volume of 107,947 shares, compared to its average volume of 132,178. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.99 and a quick ratio of 1.16. Balchem Co. has a one year low of $137.69 and a one year high of $186.03. The stock has a market cap of $4.99 billion, a price-to-earnings ratio of 38.97, a price-to-earnings-growth ratio of 4.41 and a beta of 0.75. The company has a fifty day simple moving average of $164.34 and a two-hundred day simple moving average of $167.30.

Balchem (NASDAQ:BCPC - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The basic materials company reported $1.22 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.25 by ($0.03). The company had revenue of $250.52 million for the quarter, compared to analyst estimates of $245.70 million. Balchem had a net margin of 13.47% and a return on equity of 11.37%. As a group, equities analysts forecast that Balchem Co. will post 4.64 earnings per share for the current year.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.